Axcelis Q4: Becoming More Constructive, But Some Risks Remain (ACLS)

Ignatiev

Introduction

Back in June 2023, we wrote a piece on Axcelis Technologies (NASDAQ:ACLS), a specialist in ion implantation technology, when it was flourishing at around lifetime highs. Whilst we appreciated some facets of the business (and still do), we were less certain of its ability to generate ample alpha at those lofty levels, and hence went with a HOLD rating back then.…

This data comes from the ChinaPulse.com media intelligence and smart news insights monitoring platform.